Treatment of bipolar depression with minocycline and/or aspirin: An adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial
Translational Psychiatry Jan 29, 2018
Savitz JB, et al. - In view of the evidence of chronic inflammation in bipolar disorder (BD), the efficacy of aspirin and minocycline as augmentation therapy for bipolar depression was tested. Observations revealed that aspirin or minocycline had no significant main effect on the mean change in Montgomery–Äsberg Depression Rating Scale (MADRS) score across visits. For bipolar depression, aspirin and minocycline could be efficacious adjunctive treatments.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries